diclofenac hydroxyethylpyrrolidine has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arishita, G; Chrysopoulo, M; Garza, R; Ketchum, N; Ledoux, P; Michalek, JE; Nastala, C; Ochoa, O; Pisano, S | 1 |
| Fukamachi, K; Kim, CK; Moore, MA; Naito, A; Nomoto, H; Tsuda, H | 1 |
1 review(s) available for diclofenac hydroxyethylpyrrolidine and Breast Cancer
| Article | Year |
|---|---|
Carcinogenesis and its modification by environmental endocrine disruptors: in vivo experimental and epidemiological findings.
Topics: Animals; Breast Neoplasms; DDT; Diclofenac; Endocrine System; Environmental Pollutants; Epidemiologic Studies; Female; Glycine max; Gonadal Steroid Hormones; Humans; Insecticides; Isoflavones; Male; Mice; Neoplasms; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Prostatic Neoplasms; Rats; Risk Assessment | 2003 |
1 other study(ies) available for diclofenac hydroxyethylpyrrolidine and Breast Cancer
| Article | Year |
|---|---|
Prospective Longitudinal Patient-Reported Satisfaction and Health-Related Quality of Life following DIEP Flap Breast Reconstruction: Relationship with Body Mass Index.
Topics: Adult; Body Mass Index; Breast Neoplasms; Diclofenac; Disease-Free Survival; Epigastric Arteries; Female; Graft Survival; Humans; Longitudinal Studies; Mammaplasty; Mastectomy; Middle Aged; Patient Reported Outcome Measures; Perforator Flap; Prospective Studies; Quality of Life; Rectus Abdominis; Risk Assessment; Survival Rate; Treatment Outcome; United States | 2019 |